UNSPSC 51271906: Butacaine

This classification denotes an anesthetic agent with the molecular formula C18H30N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Z84S23CGJJ, chemically known as 1-propanol, 3-(dibutylamino)-, p-aminobenzoate (ester) but generally known as butacaine, which bears US NIH Compound Identifier 2480. Butacaine most often comes in base, acetate, chloride, hydrochloride, and sulfate forms. European Medicines Agency schedules Butacaine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05994MIG.

UNSPSC 51271906 Butacaine, a Commodity code, encompasses local anesthetic agents and related pharmaceutical products that state and local health systems and correctional facilities acquire through cooperative purchasing agreements and direct procurement. Recent activity shows state and local entities purchasing generic multi-source pharmaceuticals—including local anesthetics, OTC products, and branded equivalents—through established wholesaler networks with detailed product specifications, pricing transparency, and supply chain compliance requirements. Issuing bodies include state departments of administration acting as cooperative purchasing administrators (notably the Minnesota Multistate Cooperative Purchasing Alliance), participating state and local government facilities, and healthcare systems across multiple jurisdictions. The procurement framework emphasizes cGMP certification, Drug Supply Chain Security Act compliance, contractual relationships with authorized wholesalers, and demonstrated pricing flexibility through formats such as flat pricing, net price, or WAC-minus structures.

The code shows active recent solicitation across participating states including Minnesota and Oregon. The Minnesota Department of Administration's Office of State Procurement, through MMCAP, issued a multi-award RFP (S1070000015802) posted January 20, 2026, for generic multi-source pharmaceuticals and OTC products with a March 26, 2026 response deadline. Award is contingent on vendor compliance with three authorized wholesalers (AmerisourceBergen/Cencora, Cardinal Health, and Morris & Dickson), maintenance of $5 million commercial general liability insurance and $2 million network security liability coverage, and agreement to a 3 percent administrative fee. The contract term is two years for new vendors with optional extensions, effective July 1, 2026, with evaluation weighted heavily on price competitiveness (75 percent) and administrative compliance (20 percent combined). Vendors face performance penalties of $200 to $1,500 per violation for reporting delays or onboarding failures.